Elon, Inc.

Transcript: Why Elon Musk’s Alleged Drug Use Isn’t Causing a Big Stir

Read the conversation from the latest episode of Elon, Inc. about why investors have been largely unmoved by the new Musk controversy.

Elon Musk

Photographer: Nathan Howard/Getty Images
Lock
This article is for subscribers only.

In this week’s episode of Elon, Inc., we discuss Elon Musk’s alleged drug use. Were we talking about almost any other executive, the report by the Wall Street Journal over the weekend would have qualified as a bombshell. According to the Journal’s unidentified sources, Musk’s alleged substance abuse has caused consternation within his companies, with Tesla board members and SpaceX executives privately expressing concerns.

But it’s not clear that many people inside or outside Musk’s companies are genuinely worried. Investors have been largely unmoved by all of this, partly because during the period that Musk is alleged to have indulged, he also made them a great deal of money. Musk himself mostly laughed off the report. On this episode of Elon, Inc., we are joined by Loren Grush, Bloomberg aerospace reporter and author of the NASA history The Six, to discuss why the drug allegations haven’t hurt Musk, and why a labor dispute involving SpaceX employees might be a bigger threat.

Here is a lightly edited transcript of the conversation. Listen in full below, learn more about the podcast here and subscribe on Apple and Spotify to stay on top of new episodes.